Introduction: Chronic pleural cerebrospinal fluid (CSF) effusion is a rare complication after ventriculoperitoneal (VP) shunt insertion and only 18 cases in children and adults have been described so far without catheter dislocation to the intrathoracic cavity. Case Presentation: We report on a 4-year-old girl with a complex history of underlying neurogenetic disorder, a hypoxic-ischemic encephalopathy after influenza A infection with septic shock and severe acute respiratory distress syndrome, followed by meningitis at the age of 10 months. In consequence, she developed a severe cerebral atrophy and post-meningitic hydrocephalus requiring placement of a VP shunt. At age 4, she was admitted with community-acquired mycoplasma pneumonia and developed increasing pleural effusions leading to severe respiratory distress and requiring continuous chest tube drainage (up to 1,000–1,400 mL/day) that could not be weaned. β trace protein, in CSF present at concentrations >6 mg/L, was found in the pleural fluid at low concentrations of 2.7 mg/L. An abdomino-thoracic CSF fistula was finally proven by single photon emission computerized tomography combined with low-dose computer tomography. After shunt externalization, the pleural effusion stopped and the chest tube was removed. CSF production rate remains high above 500 mL/24 h. An atrial CSF shunt could not be placed, since a hemodynamically relevant atrial septum defect with frail circulatory balance would not have tolerated the large CSF volumes. Therefore, she underwent a total bilateral endoscopic choroid plexus laser coagulation (CPC) within the lateral ventricles via bi-occipital burr holes. Postoperatively CSF production rate went close to 0 mL and after external ventricular drain removal no signs and symptoms of hydrocephalus developed during a follow-up of now 2.5 years. Conclusion: In summary, pleural effusions in patients with VP shunt can rarely be caused by an abdomino-thoracic fistula, with non-elevated β-trace protein in the pleural fluid. The majority of reported cases in literature were treated by ventriculoatrial shunt. This is the 2nd reported case, which has been successfully treated by radical CPC alone including the temporal horn choroid plexus, making the child shunt independent.

Established Facts

  • Implantation of ventriculoperitoneal (VP) shunt is a standard therapy of hydrocephalus.

  • Chronic pleural CSF effusion can occur as a very rare complication of VP shunts in case of a diaphragmatic hole with or without intrathoracic migration of the distal shunt catheter.

Novel Insights

  • Hypersecretory choroid plexus and operative manipulation of the diaphragm (fundoplication) are enabling factors for ventriculoperitoneal shunt associated pleural effusions.

  • Single photon emission tomography combined with low-dose computer tomography can reveal the existence and the location of a diaphragmatic CSF fistula by demonstrating transition of tracer from intraperitoneal to the pleural space in 3 dimensions.

  • Extensive choroid plexus coagulation is a therapeutic option to abolish hypersecretion and either render the child shunt independent or mediate an occlusion of abdomino-thoracic CSF fistula.

Implantation of ventriculoperitoneal (VP) shunts is the standard therapy of hydrocephalus in case an endoscopic procedure cannot avoid a VP shunt. Infection and mechanical shunt failures are the most frequent complications of cerebrospinal fluid (CSF) shunt therapy [1]. Thoracic complications like pleural effusion or intrathoracic migration of the distal end of the VP shunt have been rarely reported [2, 3]. The diaphragm is normally a watertight physical barrier between the peritoneal and pleural cavities. Foramen of Morgagni (sternocostal triangle) and Foramen of Bochdalek (lumbocostal triangle) are embryonic defects in the fusion of components, which can cause a congenital diaphragmatic hernia [4], pneumothorax as complication of a laparoscopy [5], acute pleural effusion as complication of peritoneal dialysis [6], or a transdiaphragmatic migration of VP shunt [7‒9]. In case of an acquired pleural effusion due to CSF fistula without an intrathoracic shunt catheter migration, it is believed that diaphragmatic defects or diaphragmatic perforation due to inflammatory processes play a role [9, 10]. Thoracentesis with chest tube placement under ultrasound guidance is an easy and safe way to acutely treat an effusion-related life-threatening respiratory decompensation [11], however, might not solve the problem of diaphragmatic fistula. We report on an unusual acquired diaphragmatic CSF fistula in coincidence of an acquired CSF hypersecretion in the presence of a VP shunt, happening in a child with severe syndromal neurological impairment with an additional postinfectious hydrocephalus after devastating influenza A sepsis and meningoencephalitis 3 years earlier.

The patient was a 4-year-old girl with a severe global developmental disorder based on a neurogenetic disease with complex unbalanced chromosomal aberration involving chromosomes 3, 9, 14, and X. The complex clinical picture includes laryngo-/tracheomalacia, hiatal hernia, gastroesophageal reflux, and neurogenic gulp disorder. At the age of 10 months, the girl had a septic shock with cardiopulmonary arrest in the context of severe pneumonia with influenza A and meningoencephalitis. The girl went into severe acute respiratory distress syndrome, requiring extracorporeal oxygenation and underwent several resuscitations. Over some months, she developed global brain atrophy plus a pressure active hydrocephalus requiring placement of a VP shunt 3 months after the influence infection. Due to a neurogenic swallowing disorder recurrent aspiration occurred, demanding a fundoplication and percutaneous endoscopic jejunostomy 1 month later. Afterward, she was stable over 3 years in a severely reduced neurological status.

At the age of 4 years, she was hospitalized because of mycoplasma pneumonia with 3 weeks persistent clinical signs. C-reactive protein was increased (19.8 mg/dL) and calculated antibiotic therapy with Piperacillin/Tazobactam and Clarithromycin was started. Microbacterial and virological findings were negative in all body fluids. Routine echocardiography showed the known 10 mm secundum atrial septum defect (ASD) with the new finding of a left-right shunting and tricuspid regurgitation grade II. A large right-sided pleural effusion was seen. Because of progressive respiratory deterioration the pleural effusion was drained by a chest tube. The clear serous fluid showed laboratory criteria of a transudate (pleural total protein 0.9 g/L, serum total protein 5.9 g/dL, ratio pleural/serum protein 0.15, pleural lactate dehydrogenase 167 U/L) and was interpreted as a complication of the pneumonia. The continuing high drainage rates up to 1,400 mL in 24 h, however, could not be explained by a pneumonia effusion and a differential diagnostic work-up trying to differentiate transudate from exsudate was not successful. Radiologically, the VP shunt was confirmed in a regular intraperitoneal position, however was partially traveling through the subphrenic suprahepatic region, with the shunt tip however in the mid abdomen. Beta trace protein, specific to CSF, could be detected in the pleural drain fluid at a concentration of 2.7 mg/L, CSF concentrations are >6 mg/L. Due to the low concentration of beta trace protein clearly below normal CSF concentration, CSF as the source of pleural secretion was considered very unlikely. To rule out any participation of the shunt system, a replacement of the shunt valve (proGAV® 5 cmH2O, gravitational unit: 25 cmH2O) and optimized placement of abdominal catheter away from the right upper abdominal quadrant resulted in no improvement of high pleural drainage fluid output. Finally, the rare occurrence of an acquired abdomino-thoracic CSF fistula was considered despite the low β-trace protein concentration. As described in literature, an abdomino-thoracic CSF fistula was visualized by single photon emission computerized tomography (SPECT), in our setting combined with low-dose computer tomography for 3D visualization. The examination demonstrated the transition of tracer injected into the shunt system from the intraperitoneal to the right pleural space in three-dimensional imaging and thus confirmed an abdomino-thoracic fistula anterior to the esophagus (shown in Fig. 1).

Fig. 1.

Single photon emission tomography combined with low-dose computed tomography of cranium and body trunk (55 min after intrathecal tracer application, blue = lower concentration of tracer, yellow = higher concentration of tracer). a Shows a frontal plane with tracer transition from intraperitoneal to pleural space anterior to the esophagus. In (b) tracer accumulates in the dorsal right lung area.

Fig. 1.

Single photon emission tomography combined with low-dose computed tomography of cranium and body trunk (55 min after intrathecal tracer application, blue = lower concentration of tracer, yellow = higher concentration of tracer). a Shows a frontal plane with tracer transition from intraperitoneal to pleural space anterior to the esophagus. In (b) tracer accumulates in the dorsal right lung area.

Close modal

The externalization of the VP shunt (with removal of valve and abdominal catheter) resulted in complete cessation of the right pleural fluid discharge and the chest tube was removed without any recurrence of pleural effusion. The option of a ventriculoatrial (VA) shunt to permanently solve the dilemma could not be chosen because the hemodynamically relevant ASD and the barely balanced cardiopulmonary system would not tolerate an additional intravascular volume load of up to 1,000 mL of CSF/24 h.

The hydrocephalus and CSF hypersecretion problem were solved with a bilateral endoscopic total choroid plexus destruction with laser from the Foramen of Monroi to the tip of the temporal horn using a bi-occipital burr hole approach. A rigid Little Lotta Pediatric Endoscope (Storz, Tuttlingen, Germany) and a Thulium Laser with 15 W power applied via 0.5 mm laser fiber (Lisa Laser, Katlenburg, Germany) were used for the procedure and the choroid plexus was coagulated and shrunk as radical as possible through both lateral ventricles. The external ventricular drain (EVD) was kept which showed that the CSF production rate came down to 0 within a few days after surgery and was consequently removed thereafter. The CT scan after choroid plexus coagulation (CPC) showed a marked opening of the previously compressed external CSF spaces and slight decrease of ventricular width (see Fig. 2). 1 Year after CPC the ASD was successfully closed using an Amplatzer® Septal Occluder.

Fig. 2.

Coronal CT scan prior to CPC (a) and 3 days after surgery after removal of the external ventricular drain (b). Clearly, the preoperatively compressed outer CSF spaces are relaxed and have opened up after CPC, the ventricles appear a bit more relaxed.

Fig. 2.

Coronal CT scan prior to CPC (a) and 3 days after surgery after removal of the external ventricular drain (b). Clearly, the preoperatively compressed outer CSF spaces are relaxed and have opened up after CPC, the ventricles appear a bit more relaxed.

Close modal

In the follow-up of 2.5 years, there was a regular course of head circumference and no neurological symptoms suspicious of active hydrocephalus. The child is shunt free and neurologically stable on her low level of cognitive and motor function at present. Therefore, no further imaging was performed until now.

As shown in big prospective trials the complication rate 1 year after VP shunt insertion is 38%, after 2 years 48%, and after 3 years 54%. Shunt obstruction was most frequently seen in the first 2 years with 75% of all complication, followed by infection with 16% and overdrainage with 7% [12]. Pleural effusion as in our patient is only very rarely reported [2, 3]. There are pleural effusions with and without migration of VP shunt in pleural cavity [9]. In the review of Ulus et al. [13], a ratio of patients with and without migration was described as 61% (n = 22) to 39% (n = 14). We have reviewed the literature and collected 18 more cases with this rare condition of pleural effusion in connection with a non-migrated VP shunt (see Table 1). Only 4 cases occurred in adults. Pleural effusions without migration are mostly a problem of childhood (14 of 19 cases, 74%, Table 1). Averaging all 19 cases, a pleural effusion occurred with a mean delay of 30 ± 73 months to insertion of VP shunt. 13 cases happened in the 1st year after insertion (63%) and 4 cases in 2nd year (21%).

Table 1.

Reported therapy options in cases of chronic pleural effusion without catheter migration as complication after VP shunt insertion

ReferenceAgeSide of effusion/side of VP shuntSymptomsDelay to shunt insertionTreatment
thoracocentesisEVDpleurodesenew DCEVPVA-SCPCETVDC
Faillace and Garrison [14], 1998 4 months both/right TP 1 months 
Hadzikaric et al. [10], 2002 16 months left/right TP, fever 16 months 
Muramatsu and Koike [15], 2004 46 years right/right bdominal distension few days 
Muramatsu and Koike [15], 2004 68 years right/right abdominal ache, TP, fever 1 months 
Adeolu et al. [16], 2005 8 years right/right TP, vomiting, headache 1.5 months 
Born et al. [17], 2008 2.5 years right/left DP, fever 2 years 
Smith and Cohen [18], 2009 14 months right/right TP 2.5 months 
Bacon and Sithamparanathan [19], 2011 35 years left/left chest pain 27 years 
Kocagullar et al. [20], 2011 5 years right/right DP 4.7 years  
Patel and Dorantes-Argandar [21], 2011 5 months right/right DP 4 months 
Sekiguchi et al. [22], 2012 61 years right/right DP, chest pain 3 months 
Ulus et al. [13], 2012 7 months right/right cough, fever, DP 7 months 
Chuen-im et al. [23], 2012 5 years right/unknown oxygen demand 4 years 
O´Halloran et al. [24], 2013 5 years right/right DP, abdominal distension 2 years 
Henningfeld et al. [28], 2016 8 months right/left mild respiratory distress 3 months 
Yéboles et al. [25], 2017 30 months right/right unknown 11 months 
Mondragón Tirado et al. [26], 2019 13 months unknown/unknown unknown 4 months 
Hilmani et al. [27], 2020 15 months right/right TP 12 months 
Current study 4 years right/right TP, fever 2 years 
ReferenceAgeSide of effusion/side of VP shuntSymptomsDelay to shunt insertionTreatment
thoracocentesisEVDpleurodesenew DCEVPVA-SCPCETVDC
Faillace and Garrison [14], 1998 4 months both/right TP 1 months 
Hadzikaric et al. [10], 2002 16 months left/right TP, fever 16 months 
Muramatsu and Koike [15], 2004 46 years right/right bdominal distension few days 
Muramatsu and Koike [15], 2004 68 years right/right abdominal ache, TP, fever 1 months 
Adeolu et al. [16], 2005 8 years right/right TP, vomiting, headache 1.5 months 
Born et al. [17], 2008 2.5 years right/left DP, fever 2 years 
Smith and Cohen [18], 2009 14 months right/right TP 2.5 months 
Bacon and Sithamparanathan [19], 2011 35 years left/left chest pain 27 years 
Kocagullar et al. [20], 2011 5 years right/right DP 4.7 years  
Patel and Dorantes-Argandar [21], 2011 5 months right/right DP 4 months 
Sekiguchi et al. [22], 2012 61 years right/right DP, chest pain 3 months 
Ulus et al. [13], 2012 7 months right/right cough, fever, DP 7 months 
Chuen-im et al. [23], 2012 5 years right/unknown oxygen demand 4 years 
O´Halloran et al. [24], 2013 5 years right/right DP, abdominal distension 2 years 
Henningfeld et al. [28], 2016 8 months right/left mild respiratory distress 3 months 
Yéboles et al. [25], 2017 30 months right/right unknown 11 months 
Mondragón Tirado et al. [26], 2019 13 months unknown/unknown unknown 4 months 
Hilmani et al. [27], 2020 15 months right/right TP 12 months 
Current study 4 years right/right TP, fever 2 years 

TP, tachypnea; DP, dyspnea; EVD, external ventricular drain; DC, distal catheter; EVP, elevation of valve pressure; VA-S, ventriculoatrial shunt; CPC, choroid plexus coagulation; ETV, endoscopic third ventriculostomy; DC, diaphragm closure.

In case of a correct position of the distal part of the VP shunt in the abdominal cavity, the true cause of pleural effusion can easily be overlooked and is not self-evident as this case shows. Bronchopulmonary infections present a difficulty in interpreting the pleural effusion and delay diagnosis and thus therapy as in our case. In our literature search, tachypnea, dyspnea, or tachydyspnea are the most common presenting symptoms (14 of 19 cases, 74%, Table 1). One case report describes symptoms of pneumonia but did not report a delay in therapy [13].

Congenital or acquired diaphragm defects, negative intrathoracic pressure, positive intra-abdominal pressure, and peritoneal reduced absorptive capacity of CSF are described as enabling factors for pleural effusion [9]. 5 of 19 cases have used SPECT detecting abdomino-thoracic fistula [13‒17]. This case report is the first using SPECT combined with low-dose CT. The exact location of the tracer transfer into the pleural space was nevertheless difficult to visualize but is interpreted to be in the area of the fundoplication ventral of the esophagus and not in the area of a suspected foramen Morgagni. In 2 further cases, fundoplication was as well reported in medical history [17, 18]. Therefore previous manipulation near to diaphragm could be a further risk factor for developing a VP shunt associated pleural effusion. Based on a gap in the diaphragm, which acts as a valve, large amounts of fluid may be suctioned to the pleural space that cannot return to the abdominal cavity. The one-way flow is probably due to a pressure gradient resulting from negative intrathoracic and positive abdominal pressure during the inspiration [17]. Due to progressive respiratory deterioration, 18 patients (95%) received thoracentesis.

Treatment in all 19 cases is shown in Table 1. One patient did not require any further treatment because the patient was clinically stable after removal of the chest tube and no renewed pleural effusion could be detected [19]. 11 of 19 patients (58%) received a change to a VA shunt [10, 13‒16, 20‒24] as definite solution. In 6/11 cases, the switch to VA shunt was performed directly, in 1/11 after externalization of the VP shunt via EVD. 2/11 cases had an EVD, then abdominal surgery with either new placement of distal catheter or closure of the diaphragmatic hole that was unsuccessful, and a secondary switch to a VA shunt was required. In 2 cases, the first unsuccessful surgery was new placement of distal catheter followed by switch to VA shunt. 3/19 patients (16%), however, were successfully treated with new placement of the distal VP shunt catheter. One patient (5%) was successfully treated with a ventriculostomy [25], 1 patient (5%) with the easy maneuver of increasing the valve pressure [26] to decrease CSF drainage rate, and 2 patients (11%), including the presented one, with CPC. The other case, who was treated with CPC, had an unsuccessful attempt of pleurodesis as first surgical intervention to treat the fistula [17].

This case, reported by Chuen-im et al. [17], did also present with an unusually high CFS production rate of approximately 800 mL/day corresponding of our case. Choroid plexus epithelium generates approximately 80% of CSF [27] and is among the most efficient secretory epithelia in the human body with a maximum production rate of 0.4 mL/min per gram of tissue rivalling the secretion rate in proximal tubule of kidney [28]. The total CFS volume of approximately 150 mL in adults is replaced 3–4 times per day corresponding with a maximum CFS production rate of 500–600 mL per day [28]. However, there is a large variability (0.11–0.73 mL/min) in CSF production rate in healthy adults [29]. The methods of measurement of CSF production rate are based on calculation by intracranial pressure measurement [29] or two-dimensional cine phase-contrast MR imaging [30] and are not very precise, especially in healthy children almost no systematic investigations exist. In a cohort of 100 children with hydrocephalus, the hourly CSF output measured through an external ventricular drainage fluctuates between 0.001 and 0.44 mL/min [31]. Chronic large amounts of CSF associated with hydrocephalus are compatible with choroid plexus hyperplasia or nonobstructive tumors of the choroid plexus, such as a choroid plexus papilloma (CPP) [32], which could not be seen in our patient. Idiopathic intracranial hypertension [33], infectious hydrocephalus [34], and intraventricular hemorrhage-associated hydrocephalus [35] are also named as reason for an increased CSF production rate. Our patient had history of an infectious hydrocephalus years ago, but it is unlikely to consider this event in the past to be the cause of hypersecretion, after the patient had no evidence of high-volume CSF shunting rates, like ascites, in the 2 years prior to the occurrence of the fistula. As described for patient with choroid plexus hyperplasia or CPP, showing a significant decrease of CSF production after endoscopic CPC [28], our patient did benefit of a total bilateral CPC. Because of the high CSF production rate, we wanted to be as radical in lateral ventricle CPC as possible and treat all choroid plexus in the lateral ventricles including all plexus in the temporal horns. Since we did lack a flexible endoscope, we chose the unusual approach with a bilateral occipital burr hole that allowed to reach with a rigid scope bilaterally the entire choroid plexus from the tip of the temporal horn to the foramen of Monroi. After CPC, the production rate of the external CSF drainage was very low and ceased after 2 days. After removal of the EVD, there was no further need of a shunt corresponding with some case reports in patients with CPP [28, 36‒38]. Chuen-im et al. [17] assumed that the increased CSF production rate presented presumably throughout the whole life, without having any valid findings to support this claim. In interpreting our patient, it is be difficult to separate a congenital and a postinfectious component for hydrocephalus and we have no explanation why the girl developed hypersecretion. We cannot even rule out, that the unusually high CSF output rates through the chest tube were secondary to the loss of the usual intra-abdominal counter pressure, that ranges between 4 and 5 mm Hg in supine [39] position that usually exists in VP shunts and decreases the pressure differential that allows shunt flow. In view of the still insufficient understanding of the genetic components of developmental hydrocephalus [28], genetic involvement appears to be possible in our patient with a pronounced chromosomal disorder.

Abdomino-thoracic CSF fistulas in patients with VP shunts are a rare occurrence but have been described in all together 19 case reports, 15 of which were in children. The existence of such a fistula needs to be ruled out in children with VP shunts if a pleural effusion is detected and no other obvious cause can be identified. A β-trace protein concentration in pleural fluid below the usual CSF concentration of this protein does not exclude CSF as origin of the pleural effusion. Single photon emission tomography after injection of the traces inside the shunt system combined with computer tomography can reveal the transition of CSF from intraperitoneal to the pleural space and with a better 3-dimensional interpretation than in SPECT alone might identify the presumable location of the transition point in the diaphragm. In addition to diaphragmatic defects, negative intrathoracic pressure, positive intra-abdominal pressure and peritoneally reduced CSF uptake capacity, increased CSF production and manipulation near to diaphragm are enabling factors for a pleural effusion. Radical CPC in both lateral ventricles can be an alternative therapy option, also in hyper-secretive choroid plexus, if a switch to a VA shunt is either not possible or not wanted.

Written informed consent was obtained from the parents of the patient for publication of the details of their medical case and any accompanying images. This study protocol was reviewed and approved by Ethics Committee at the Medical Faculty of Eberhard Karls University and at the University Hospital Tübingen, approval number 142/2022A.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The authors received no specific funding for this work.

S. Schmid and M. Schumann initiated and designed the article. M. Hofbeck, A. Bevot, M. Reimold, M. Kumpf, J. Michel, and F. Neunhoeffer provided important aspects for analysis and interpretation and critically revised the final version.

All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.

1.
Kahle
KT
,
Kulkarni
AV
,
Limbrick
DD
,
Warf
BC
.
Hydrocephalus in children
.
Lancet
.
2016 Feb 20
387
10020
788
99
.
2.
Taub
E
,
Lavyne
MH
.
Thoracic complications of ventriculoperitoneal shunts: case report and review of the literature
.
Neurosurgery
.
1994 Jan
34
1
181
3
; discussion 183-4
3.
Blount
JP
,
Campbell
JA
,
Haines
SJ
.
Complications in ventricular cerebrospinal fluid shunting
.
Neurosurg Clin N Am
.
1993 Oct
4
4
633
56
.
4.
Nason
LK
,
Walker
CM
,
McNeeley
MF
,
Burivong
W
,
Fligner
CL
,
Godwin
JD
.
Imaging of the diaphragm: anatomy and function
.
Radiographics
.
2012 Mar-Apr
32
2
E51
70
.
5.
Azocar
RJ
,
Rios
JR
,
Hassan
M
.
Spontaneous pneumothorax during laparoscopic adrenalectomy secondary to a congenital diaphragmatic defect
.
J Clin Anesth
.
2002 Aug
14
5
365
7
.
6.
Dang
MH
,
Mathew
M
,
Raj
R
.
Pleuroperitoneal leak as an uncommon cause of pleural effusion in peritoneal dialysis: a case report and literature review
.
Case Rep Nephrol
.
2020
;
2020
:
8832080
.
7.
Martin
LM
,
Donaldson-Hugh
ME
,
Cameron
MM
.
Cerebrospinal fluid hydrothorax caused by transdiaphragmatic migration of a ventriculoperitoneal catheter through the foramen of Bochdalek
.
Childs Nerv Syst
.
1997 May
13
5
282
4
.
8.
Lundy
PA
,
Partington
MD
,
Tuchek
CA
,
Garcia
DM
.
Intrathoracic migration of ventriculo-peritoneal shunt via Morgagni hernia
.
Childs Nerv Syst
.
2021 01
37
1
345
7
.
9.
Porcaro
F
,
Procaccini
E
,
Paglietti
MG
,
Schiavino
A
,
Petreschi
F
,
Cutrera
R
.
Pleural effusion from intrathoracic migration of a ventriculo-peritoneal shunt catheter: pediatric case report and review of the literature
.
Ital J Pediatr
.
2018 Mar 27
44
1
42
.
10.
Hadzikaric
N
,
Nasser
M
,
Mashani
A
,
Ammar
A
.
CSF hydrothorax: VP shunt complication without displacement of a peritoneal catheter
.
Childs Nerv Syst
.
2002 Apr
18
3–4
179
82
.
11.
Fraga
MV
,
Stoller
JZ
,
Glau
CL
,
De Luca
D
,
Rempell
RG
,
Wenger
JL
.
Seeing is believing: ultrasound in pediatric procedural performance
.
Pediatrics
.
2019 11
144
5
e20191401
.
12.
Kestle
J
,
Drake
J
,
Milner
R
,
Sainte-Rose
C
,
Cinalli
G
,
Boop
F
.
Long-term follow-up data from the shunt design trial
.
Pediatr Neurosurg
.
2000 Nov
33
5
230
6
.
13.
Ulus
A
,
Kuruoglu
E
,
Ozdemir
SM
,
Yapici
O
,
Sensoy
G
,
Yarar
E
.
CSF hydrothorax: neither migration of peritoneal catheter into the chest nor ascites. Case report and review of the literature
.
Childs Nerv Syst
.
2012 Nov
28
11
1843
8
.
14.
Faillace
WJ
,
Garrison
RD
.
Hydrothorax after ventriculoperitoneal shunt placement in a premature infant: an iatrogenic postoperative complication. Case report
.
J Neurosurg
.
1998 Mar
88
3
594
7
.
15.
Kocaogullar
Y
,
Güney
O
,
Kaya
B
,
Erdi
F
.
CSF hydrothorax after ventriculoperitoneal shunt without catheter migration: a case report
.
Neurol Sci
.
2011 Oct
32
5
949
52
.
16.
Patel
AP
,
Dorantes-Argandar
A
,
Raja
AI
.
Cerebrospinal fluid hydrothorax without ventriculoperitoneal shunt migration in an infant
.
Pediatr Neurosurg
.
2011
;
47
(
1
):
74
7
.
17.
Chuen-im
P
,
Smyth
MD
,
Segura
B
,
Ferkol
T
,
Rivera-Spoljaric
K
.
Recurrent pleural effusion without intrathoracic migration of ventriculoperitoneal shunt catheter: a case report
.
Pediatr Pulmonol
.
2012 Jan
47
1
91
5
.
18.
Spennato
P
,
Tazi
S
,
Bekaert
O
,
Cinalli
G
,
Decq
P
.
Endoscopic third ventriculostomy for idiopathic aqueductal stenosis
.
World Neurosurg
.
2013 Feb
79
2
S21.e13
20
.
19.
Yéboles
RM
,
Vázquez
L
,
Seoane
M
,
Castro
S
,
Ruiz
B
.
[Hydrothorax as a complication of a ventricle peritoneal shunt. A case report]
.
Neurocirugia
.
2017 Jul–Aug
28
4
202
6
.
20.
Muramatsu
H
,
Koike
K
.
Pleural effusions appearing in the rehabilitation ward after ventriculoperitoneal shunts: a report of two adult cases and a review of the literature
.
Brain Inj
.
2004 Aug
18
8
835
44
.
21.
Smith
JC
,
Cohen
E
.
Beta-2-transferrin to detect cerebrospinal fluid pleural effusion: a case report
.
J Med Case Rep
.
2009 Mar 13
3
6495
.
22.
O’Halloran
PJ
,
Kaliaperumal
C
,
Caird
J
.
Chemotherapy-induced cerebrospinal fluid malabsorption in a shunted child: case report and review of the literature
.
BMJ Case Rep
.
2013 Feb 8
2013
.
23.
Hilmani
S
,
Mesbahi
T
,
Bouaggad
A
,
Lakhdar
A
.
A rare complication of ventriculoperitoneal shunt: pleural effusion without intrathoracic ventriculoperitoneal shunt catheter
.
Surg Neurol Int
.
2020
;
11
:
291
.
24.
Henningfeld
J
,
Loomba
RS
,
Encalada
S
,
Magner
K
,
Pfister
J
,
Matthews
A
.
Pleural effusion in a child with a ventriculoperitoneal shunt and congenital heart disease
.
Springerplus
.
2016
;
5
:
90
.
25.
Sekiguchi
H
,
Suzuki
J
,
Wetjen
NM
,
Mullon
JJ
.
Recurrent cerebrospinal fluid (CSF) pleural effusions caused by ventriculoperitoneal (VP) shunt: a case with a successful treatment with endoscopic third ventriculostomy
.
Clin Neurol Neurosurg
.
2013 Jul
115
7
1190
3
.
26.
Mondragón Tirado
CA
,
Giménez-Pando
J
,
Torres-De Aguirre
AM
,
Grande-Tejada
A
,
Gilete-Tejero
IJ
,
Botana-Fernández
M
.
Pleural effusion in a child with a correctly placed ventricle-peritoneal shunt
.
Br J Neurosurg
.
2019
1
5
. [published online: October 30
27.
Brinker
T
,
Stopa
E
,
Morrison
J
,
Klinge
P
.
A new look at cerebrospinal fluid circulation
.
Fluids Barriers CNS
.
2014
;
11
:
10
.
28.
Karimy
JK
,
Duran
D
,
Hu
JK
,
Gavankar
C
,
Gaillard
JR
,
Bayri
Y
.
Cerebrospinal fluid hypersecretion in pediatric hydrocephalus
.
Neurosurg Focus
.
2016 Nov
41
5
E10
.
29.
Edsbagge
M
,
Tisell
M
,
Jacobsson
L
,
Wikkelso
C
.
Spinal CSF absorption in healthy individuals
.
Am J Physiol Regul Integr Comp Physiol
.
2004 Dec
287
6
R1450
5
.
30.
Huang
TY
,
Chung
HW
,
Chen
MY
,
Giiang
LH
,
Chin
SC
,
Lee
CS
.
Supratentorial cerebrospinal fluid production rate in healthy adults: quantification with two-dimensional cine phase-contrast MR imaging with high temporal and spatial resolution
.
Radiology
.
2004 Nov
233
2
603
8
.
31.
Yasuda
T
,
Tomita
T
,
McLone
DG
,
Donovan
M
.
Measurement of cerebrospinal fluid output through external ventricular drainage in one hundred infants and children: correlation with cerebrospinal fluid production
.
Pediatr Neurosurg
.
2002 Jan
36
1
22
8
.
32.
Bettegowda
C
,
Adogwa
O
,
Mehta
V
,
Chaichana
KL
,
Weingart
J
,
Carson
BS
.
Treatment of choroid plexus tumors: a 20-year single institutional experience
.
J Neurosurg Pediatr
.
2012 Nov
10
5
398
405
.
33.
Strahle
J
,
Garton
HJ
,
Maher
CO
,
Muraszko
KM
,
Keep
RF
,
Xi
G
.
Mechanisms of hydrocephalus after neonatal and adult intraventricular hemorrhage
.
Transl Stroke Res
.
2012 Jul
3
Suppl 1
25
38
.
34.
Cardia
E
,
Molina
D
,
Abbate
F
,
Mastroeni
P
,
Stassi
G
,
Germanà
GP
.
Morphological modifications of the choroid plexus in a rodent model of acute ventriculitis induced by gram-negative liquoral sepsis. Possible implications in the pathophysiology of hypersecretory hydrocephalus
.
Childs Nerv Syst
.
1995 Sep
11
9
511
6
.
35.
Iencean
SM
.
Simultaneous hypersecretion of CSF and of brain interstitial fluid causes idiopathic intracranial hypertension
.
Med Hypotheses
.
2003 Nov-Dec
61
5–6
529
32
.
36.
D’Ambrosio
AL
,
O’Toole
JE
,
Connolly
ES
,
Feldstein
NA
.
Villous hypertrophy versus choroid plexus papilloma: a case report demonstrating a diagnostic role for the proliferation index
.
Pediatr Neurosurg
.
2003 Jul
39
2
91
6
.
37.
Gudeman
SK
,
Sullivan
HG
,
Rosner
MJ
,
Becker
DP
.
Surgical removal of bilateral papillomas of the choroid plexus of the lateral ventricles with resolution of hydrocephalus. Case report
.
J Neurosurg
.
1979 May
50
5
677
81
.
38.
Hirano
H
,
Hirahara
K
,
Asakura
T
,
Shimozuru
T
,
Kadota
K
,
Kasamo
S
.
Hydrocephalus due to villous hypertrophy of the choroid plexus in the lateral ventricles. Case report
.
J Neurosurg
.
1994 Feb
80
2
321
3
.
39.
Böse
B
,
Rohde
V
,
Fiss
I
,
Freimann
FB
.
A counterforce to diversion of cerebrospinal fluid during ventriculoperitoneal shunting: the intraperitoneal pressure. An observational study
.
Acta Neurochir
.
2018 Mar
160
3
519
24
.
40.
Adeolu
AA
,
Komolafe
EO
,
Abiodun
AA
,
Adetiloye
VA
.
Symptomatic pleural effusion without intrathoracic migration of ventriculoperitoneal shunt catheter
.
Childs Nerv Syst
.
2006 Feb
22
2
186
8
.
41.
Born
M
,
Reichling
S
,
Schirrmeister
J
.
Pleural effusion: beta-trace protein in diagnosing ventriculoperitoneal shunt complications
.
J Child Neurol
.
2008 Jul
23
7
810
2
.
42.
Bacon
JL
,
Sithamparanathan
S
.
A rare cause of pleural effusion
.
Respir Med CME
.
2011
;
4
(
3
):
124
5
.